Evaluation and comparison of bioinformatic tools for the enrichment analysis of metabolomics data.
Evaluation and comparison of bioinformatic tools for the enrichment analysis of metabolomics data.
复制标题
DOI:
10.1186/s12859-017-2006-0
复制
发表时间:
2018-01-02
影响因子:
3
通讯作者:
Andres-Lacueva C
中科院分区:
文献类型:
--
作者:
Marco-Ramell A;Palau-Rodriguez M;Alay A;Tulipani S;Urpi-Sarda M;Sanchez-Pla A;Andres-Lacueva C
Bioinformatic tools for the enrichment of ‘omics’ datasets facilitate interpretation and understanding of data. To date few are suitable for metabolomics datasets. The main objective of this work is to give a critical overview, for the first time, of the performance of these tools. To that aim, datasets from metabolomic repositories were selected and enriched data were created. Both types of data were analysed with these tools and outputs were thoroughly examined. An exploratory multivariate analysis of the most used tools for the enrichment of metabolite sets, based on a non-metric multidimensional scaling (NMDS) of Jaccard’s distances, was performed and mirrored their diversity. Codes (identifiers) of the metabolites of the datasets were searched in different metabolite databases (HMDB, KEGG, PubChem, ChEBI, BioCyc/HumanCyc, LipidMAPS, ChemSpider, METLIN and Recon2). The databases that presented more identifiers of the metabolites of the dataset were PubChem, followed by METLIN and ChEBI. However, these databases had duplicated entries and might present false positives. The performance of over-representation analysis (ORA) tools, including BioCyc/HumanCyc, ConsensusPathDB, IMPaLA, MBRole, MetaboAnalyst, Metabox, MetExplore, MPEA, PathVisio and Reactome and the mapping tool KEGGREST, was examined. Results were mostly consistent among tools and between real and enriched data despite the variability of the tools. Nevertheless, a few controversial results such as differences in the total number of metabolites were also found. Disease-based enrichment analyses were also assessed, but they were not found to be accurate probably due to the fact that metabolite disease sets are not up-to-date and the difficulty of predicting diseases from a list of metabolites. We have extensively reviewed the state-of-the-art of the available range of tools for metabolomic datasets, the completeness of metabolite databases, the performance of ORA methods and disease-based analyses. Despite the variability of the tools, they provided consistent results independent of their analytic approach. However, more work on the completeness of metabolite and pathway databases is required, which strongly affects the accuracy of enrichment analyses. Improvements will be translated into more accurate and global insights of the metabolome. The online version of this article (10.1186/s12859-017-2006-0) contains supplementary material, which is available to authorized users.
登录
查看更多内容
影响因子:
--
作者:
Kuo TC;Tian TF;Tseng YJ
通讯作者:
Tseng YJ
影响因子:
--
作者:
Byrnes RW;Cotter D;Maer A;Li J;Nadeau D;Subramaniam S
通讯作者:
Subramaniam S
影响因子:
14.9
作者:
Kim S;Thiessen PA;Bolton EE;Chen J;Fu G;Gindulyte A;Han L;He J;He S;Shoemaker BA;Wang J;Yu B;Zhang J;Bryant SH
通讯作者:
Bryant SH
影响因子:
11.5
作者:
Hart, Christopher D.;Vignoli, Alessia;Di Leo, Angelo
通讯作者:
Di Leo, Angelo
影响因子:
14.9
作者:
Frolkis A;Knox C;Lim E;Jewison T;Law V;Hau DD;Liu P;Gautam B;Ly S;Guo AC;Xia J;Liang Y;Shrivastava S;Wishart DS
通讯作者:
Wishart DS